Movement Alert｜HBM HOLDINGS-B Falls 5.93% in Regular Trading, Biotechnology Sector Pressured by Overnight US Pharma Selloff

Market Focus

7 hours ago

On October 8, HBM HOLDINGS-B fell 5.93% in regular trading, trading at HK$12.04, with Turnover of HK$23.79 million.

The decline extended the previous day's 6.74% drop, as the biotechnology sector remained under pressure following a sharp overnight selloff in US pharmaceutical stocks. Market sentiment weakened after Moderna plunged 8% and Ailisi Pharmaceutical lost 46.98% on clinical trial setbacks, triggering a broad retreat across Hong Kong's biotech complex.

Within the Biotechnology sector, AKESO edged up 0.55%, CANSINOBIO fell 2.79%, INNOVENT BIO slipped 0.26%, BEONE MEDICINES rose 0.28%, and 3SBIO gained 0.45%.

HBM HOLDINGS-B is an investment holding company principally engaged in the development of innovative therapies in the fields of tumor immunology and immunological diseases, with products including batoclimab, HBM9378, HBM7020, TCE Program, prusabatacept, and HBM7022, targeting indications such as generalized myasthenia gravis, COPD, asthma, autoimmune diseases, melanoma, colorectal cancer, and solid tumors.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

1
2
3
4
5
6
7
8
9
10

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.etasphere.com/news/1157029864"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1157029864\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1157029864?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-10-08 09:37","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1157029864","market":"hk","top_or_hot":-1,"title":"Movement Alert｜HBM HOLDINGS-B Falls 5.93% in Regular Trading, Biotechnology Sector Pressured by Overnight US Pharma Selloff","media":"Market Focus","content":"<p><p>On October 8, HBM HOLDINGS-B fell 5.93% in regular trading, trading at HK$12.04, with Turnover of HK$23.79 million.</p><p>The decline extended the previous day's 6.74% drop, as the biotechnology sector remained under pressure following a sharp overnight selloff in US pharmaceutical stocks. Market sentiment weakened after Moderna plunged 8% and Ailisi Pharmaceutical lost 46.98% on clinical trial setbacks, triggering a broad retreat across Hong Kong's biotech complex.</p><p>Within the Biotechnology sector, AKESO edged up 0.55%, CANSINOBIO fell 2.79%, INNOVENT BIO slipped 0.26%, BEONE MEDICINES rose 0.28%, and 3SBIO gained 0.45%.</p><p>HBM HOLDINGS-B is an investment holding company principally engaged in the development of innovative therapies in the fields of tumor immunology and immunological diseases, with products including batoclimab, HBM9378, HBM7020, TCE Program, prusabatacept, and HBM7022, targeting indications such as generalized myasthenia gravis, COPD, asthma, autoimmune diseases, melanoma, colorectal cancer, and solid tumors.</p><p>(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)</p></p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Movement Alert｜HBM HOLDINGS-B Falls 5.93% in Regular Trading, Biotechnology Sector Pressured by Overnight US Pharma Selloff</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nMovement Alert｜HBM HOLDINGS-B Falls 5.93% in Regular Trading, Biotechnology Sector Pressured by Overnight US Pharma Selloff\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1054767329\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/51943b2858f75e05ca2ebb144b4e626a);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Market Focus </p>\n<p class=\"h-time\">2026-10-08 09:37</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p><p>On October 8, HBM HOLDINGS-B fell 5.93% in regular trading, trading at HK$12.04, with Turnover of HK$23.79 million.</p><p>The decline extended the previous day's 6.74% drop, as the biotechnology sector remained under pressure following a sharp overnight selloff in US pharmaceutical stocks. Market sentiment weakened after Moderna plunged 8% and Ailisi Pharmaceutical lost 46.98% on clinical trial setbacks, triggering a broad retreat across Hong Kong's biotech complex.</p><p>Within the Biotechnology sector, AKESO edged up 0.55%, CANSINOBIO fell 2.79%, INNOVENT BIO slipped 0.26%, BEONE MEDICINES rose 0.28%, and 3SBIO gained 0.45%.</p><p>HBM HOLDINGS-B is an investment holding company principally engaged in the development of innovative therapies in the fields of tumor immunology and immunological diseases, with products including batoclimab, HBM9378, HBM7020, TCE Program, prusabatacept, and HBM7022, targeting indications such as generalized myasthenia gravis, COPD, asthma, autoimmune diseases, melanoma, colorectal cancer, and solid tumors.</p><p>(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)</p></p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"02142","symbol_name":"和铂医药-B","start_time":0,"source_url":"","article_id":"1157029864","we_media_id":"1054767329","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1157029864","pubTimestamp":1791423459,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Market Focus","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1054767329","head_image":"https://static.tigerbbs.com/51943b2858f75e05ca2ebb144b4e626a"},"summary":"On October 8, HBM HOLDINGS-B fell 5.93% in regular trading, trading at HK$12.04, with Turnover of HK$23.79 million.The decline extended the previous day's 6.74% drop, as the biotechnology sector...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"02142":"和铂医药-B"},"translate_title":"走势提醒|HBM HOLDINGS-B 常规交易中下跌 5.93%，生物技术板块受到隔夜美国制药抛售的压力","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"02142":1},"content_text":"On October 8, HBM HOLDINGS-B fell 5.93% in regular trading, trading at HK$12.04, with Turnover of HK$23.79 million.The decline extended the previous day's 6.74% drop, as the biotechnology sector remained under pressure following a sharp overnight selloff in US pharmaceutical stocks. Market sentiment weakened after Moderna plunged 8% and Ailisi Pharmaceutical lost 46.98% on clinical trial setbacks, triggering a broad retreat across Hong Kong's biotech complex.Within the Biotechnology sector, AKESO edged up 0.55%, CANSINOBIO fell 2.79%, INNOVENT BIO slipped 0.26%, BEONE MEDICINES rose 0.28%, and 3SBIO gained 0.45%.HBM HOLDINGS-B is an investment holding company principally engaged in the development of innovative therapies in the fields of tumor immunology and immunological diseases, with products including batoclimab, HBM9378, HBM7020, TCE Program, prusabatacept, and HBM7022, targeting indications such as generalized myasthenia gravis, COPD, asthma, autoimmune diseases, melanoma, colorectal cancer, and solid tumors.(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"-1","news_tag":"","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"}}}